Anti-FBLIM1 monoclonal antibody

Pre-made anti-FBLIM1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FBLIM1/FBLIM1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2495-Ab-1/ GM-Tg-hg-IP2495-Ab-2Anti-Human FBLIM1 monoclonal antibodyHuman
GM-Tg-rg-IP2495-Ab-1/ GM-Tg-rg-IP2495-Ab-2Anti-Rat FBLIM1 monoclonal antibodyRat
GM-Tg-mg-IP2495-Ab-1/ GM-Tg-mg-IP2495-Ab-2Anti-Mouse FBLIM1 monoclonal antibodyMouse
GM-Tg-cynog-IP2495-Ab-1/ GM-Tg-cynog-IP2495-Ab-2Anti-Cynomolgus/ Rhesus macaque FBLIM1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2495-Ab-1/ GM-Tg-felg-IP2495-Ab-2Anti-Feline FBLIM1 monoclonal antibodyFeline
GM-Tg-cang-IP2495-Ab-1/ GM-Tg-cang-IP2495-Ab-2Anti-Canine FBLIM1 monoclonal antibodyCanine
GM-Tg-bovg-IP2495-Ab-1/ GM-Tg-bovg-IP2495-Ab-2Anti-Bovine FBLIM1 monoclonal antibodyBovine
GM-Tg-equg-IP2495-Ab-1/ GM-Tg-equg-IP2495-Ab-2Anti-Equine FBLIM1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2495-Ab-1/ GM-Tg-hg-IP2495-Ab-2; GM-Tg-rg-IP2495-Ab-1/ GM-Tg-rg-IP2495-Ab-2;
GM-Tg-mg-IP2495-Ab-1/ GM-Tg-mg-IP2495-Ab-2; GM-Tg-cynog-IP2495-Ab-1/ GM-Tg-cynog-IP2495-Ab-2;
GM-Tg-felg-IP2495-Ab-1/ GM-Tg-felg-IP2495-Ab-2; GM-Tg-cang-IP2495-Ab-1/ GM-Tg-cang-IP2495-Ab-2;
GM-Tg-bovg-IP2495-Ab-1/ GM-Tg-bovg-IP2495-Ab-2; GM-Tg-equg-IP2495-Ab-1/ GM-Tg-equg-IP2495-Ab-2
Products NameAnti-FBLIM1 monoclonal antibody
Formatmab
Target NameFBLIM1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FBLIM1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2495-Ag-1Recombinant multi-species FBLI1/ FBLIM1/ CAL protein


    Target information

    Target IDGM-IP2495
    Target NameFBLIM1
    Gene ID54751,74202,362650,695727,608618,101082251,767833,100053896
    Gene Symbol and Synonyms2410043F08Rik,CAL,FBLIM1,FBLP-1,FBLP1,Gt10,hnRNP L,Hnrnpl,migfilin,migfilin(s)
    Uniprot AccessionQ8WUP2,F1LQ48,Q1JQB5
    Uniprot Entry NameFBLI1_HUMAN,HNRPL_RAT,FBLI1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000162458
    Target ClassificationN/A

    The target: FBLIM1, gene name: FBLIM1, also named as CAL, FBLP-1, FBLP1. This gene encodes a protein with an N-terminal filamin-binding domain, a central proline-rich domain, and, multiple C-terminal LIM domains. This protein localizes at cell junctions and may link cell adhesion structures to the actin cytoskeleton. This protein may be involved in the assembly and stabilization of actin-filaments and likely plays a role in modulating cell adhesion, cell morphology and cell motility. This protein also localizes to the nucleus and may affect cardiomyocyte differentiation after binding with the CSX/NKX2-5 transcription factor. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.